Results 4,621-4,640 of 11,187 for speaker:Colm Burke

Written Answers — Department of Health: Health Strategies (12 Jul 2022)

Colm Burke: 978. To ask the Minister for Health the work that has been done to prioritise the remaining actions in the National Rare Disease Plan 2014-2018; the deadlines for implementing these actions; the progress that has been made to date; and if he will make a statement on the matter. [37814/22]

Written Answers — Department of Health: Health Strategies (12 Jul 2022)

Colm Burke: 979. To ask the Minister for Health if a new liaison person within his Department has been appointed to oversee implementation of the National Rare Disease Plan; if a review conducted by the former liaison person will be published; and if he will make a statement on the matter. [37815/22]

Written Answers — Department of Health: Health Strategies (12 Jul 2022)

Colm Burke: 992. To ask the Minister for Health if a position has been identified within his Department that focuses solely on rare disease policy; if he plans to establish such a position for rare disease policy; and if he will make a statement on the matter. [37832/22]

Written Answers — Department of Health: Health Strategies (12 Jul 2022)

Colm Burke: 993. To ask the Minister for Health the status of all programme for Government commitments to ensure an increased focus on rare diseases as outlined in the programme for Government; and if he will make a statement on the matter. [37834/22]

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 980. To ask the Minister for Health the extent of engagement that he has had with his Department officials on the Health (Pricing and Supply of Medical Goods) (Amendment) Private Members Bill 2021 that is due for Committee Stage; and if he will make a statement on the matter. [37816/22]

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 981. To ask the Minister for Health his views on the Health (Pricing and Supply of Medical Goods) (Amendment) Bill 2021; if he supports the proposed amendment to the Health Act 2013; and if he will make a statement on the matter. [37817/22]

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 984. To ask the Minister for Health if he intends to amend the Health Act 2013 to account for the unique context surrounding orphan medicinal products and advanced therapy medicinal products such as gene therapy; and if he will make a statement on the matter. [37820/22]

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 986. To ask the Minister for Health the steps that can be taken to expedite the drug reimbursement process to account for the life-threatening nature of rare diseases; if he plans to make changes to the reimbursement process in Ireland that would enable expedited access for patients with severe unmet needs; and if he will make a statement on the matter. [37822/22]

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 989. To ask the Minister for Health his views on the continued use of the quality-adjusted life year threshold in respect of the drug reimbursement process; if his attention has been drawn to the negative consequences of the use of the QALY as a cost-effectiveness tool can have on serving the unmet needs of rare disease patients; and if he will make a statement on the matter. [37829/22]

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 983. To ask the Minister for Health if Ireland is currently in breach of the European Union Transparency Directive 89/105/EEC; if his Department intends to reduce the ongoing delays for patients to gain access to European Medicines Agency-approved medicine in Ireland; and if he will make a statement on the matter. [37819/22]

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 985. To ask the Minister for Health the work that is being carried out to enhance transparency and improve communication with patient groups and industry during the drug reimbursement process; if he will provide a mechanism for patient groups and industry to establish communication with the HSE corporate pharmaceutical unit throughout the reimbursement process; and if he will make a statement...

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 987. To ask the Minister for Health if his Department has examined international best practice such as those in Scotland and Germany on the matter of interim and early access reimbursement models; and if he will make a statement on the matter. [37823/22]

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Colm Burke: 988. To ask the Minister for Health the engagement that he has had with his Department officials and HSE officials regarding the use of innovative payment models between industry and the State in respect of the drug reimbursement process for rare disease therapies; if he will provide innovative solutions to ensure greater access; and if he will make a statement on the matter. [37824/22]

Written Answers — Department of Health: Healthcare Infrastructure Provision (12 Jul 2022)

Colm Burke: 990. To ask the Minister for Health his plans to improve the health data infrastructure of the State; the way that these plans can support innovative payment models in respect of the reimbursement of orphan medicinal products and advanced therapy medicinal products; and if he will make a statement on the matter. [37830/22]

Written Answers — Department of Health: Healthcare Policy (12 Jul 2022)

Colm Burke: 991. To ask the Minister for Health the person within the HSE who decides if a product is experimental in respect of the treatment abroad scheme; the criteria that this decision maker uses to decide such and the definitions applied to experimental treatments; if the relevant decision makers have the expertise to review drugs for complex conditions; if the existing reimbursement list is...

Written Answers — Department of Health: Health Service Executive (12 Jul 2022)

Colm Burke: 1024. To ask the Minister for Health if the HSE will provide funding immediately and on an ongoing basis to directly fund a group (details supplied) in Cork, which provides essential care for a large number of children with sight loss and other disabilities, given that it currently relies on donations for funding; and if he will make a statement on the matter. [37915/22]

Written Answers — Department of Health: Healthcare Infrastructure Provision (12 Jul 2022)

Colm Burke: 1025. To ask the Minister for Health if a decision has been made as to the preferred location of the new proposed elective hospital for Cork; when an announcement will be made; and if he will make a statement on the matter. [37916/22]

Written Answers — Department of Agriculture, Food and the Marine: Forestry Sector (12 Jul 2022)

Colm Burke: 1128. To ask the Minister for Agriculture, Food and the Marine the number of forestry licences issued for private felling and for Coillte felling, respectively, per week from 1 January to 30 June 2022; the number of forestry licences issued in the same timeframe in 2021, in tabular form; if these figures are on target, as per the Forestry Licensing Plan 2022; and if he will make a statement...

Public Accounts Committee: 2020 Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 26 - Education
2018 Report on the Accounts of the Public Services of the Comptroller and Auditor General
Chapter 7 - Purchase of Sites for School Provision
2019 Report on the Accounts of the Public Services of the Comptroller and Auditor General
Chapter 8 - Management of the Schools Estate (7 Jul 2022)

Colm Burke: I thank all the departmental officials for the work they have been doing, especially in the context of the Covid-19 pandemic. It has been a challenging time. Turning to deal with the schools building process and the process we have regarding schools building projects, and especially the tendering process, the whole context of the system has now changed. A tender could be submitted today...

Public Accounts Committee: 2020 Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 26 - Education
2018 Report on the Accounts of the Public Services of the Comptroller and Auditor General
Chapter 7 - Purchase of Sites for School Provision
2019 Report on the Accounts of the Public Services of the Comptroller and Auditor General
Chapter 8 - Management of the Schools Estate (7 Jul 2022)

Colm Burke: The problem is really with the timescale from when tenders are received to when the contract is awarded to the tenderer the Department deems appropriate to undertake the job. Has this aspect been examined in respect of determining whether it can be expedited to secure progress and move these projects forward? I know of other projects, not involving this Department, where there was such a...